150carton
Wellbutrin Tablet, Extended Release
Product Images NDC 0187-0731
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Wellbutrin (NDC 0187-0731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
300carton
Wellbutrin Chemical Structure (Image 01)
Image 02
This is a list of symptoms that may be experienced by individuals trying to quit smoking. The symptoms may include an increased urge to smoke, depressed mood, trouble sleeping, irritability, frustration, anger, feeling anxious, difficulty concentrating, restlessness, decreased heart rate, increased appetite, and weight gain.*
Image 03
This text appears to be a list of symptoms that someone may experience. The symptoms mentioned are trouble sleeping, stuffy nose, dry mouth, dizziness, feeling anxious, nausea, constipation, and body aches. These symptoms may be indicative of a medical condition, but without more information, it is difficult to determine a specific diagnosis.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
